Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine in Children Aged 6 Months to 17 Years
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 12 Feb 2018
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors sanofi pasteur
- 08 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 05 Feb 2018 Planned End Date changed from 1 Jul 2018 to 4 Sep 2018.
- 05 Feb 2018 Planned primary completion date changed from 1 Feb 2018 to 30 Mar 2018.